UiPath stock: CEO share sale filing puts PATH in focus ahead of a busy week

UiPath stock: CEO share sale filing puts PATH in focus ahead of a busy week

New York, Jan 11, 2026, 18:13 EST — The market has closed.

  • UiPath CEO Daniel Dines reported selling 45,000 shares in a regulatory filing
  • Shares ended Friday down 3.3%, closing at $16.32
  • Investors are eyeing Tuesday’s CPI report alongside UiPath’s upcoming slot at the Needham conference

Shares of UiPath Inc are set to open Monday in the U.S. following a regulatory filing revealing CEO Daniel Dines sold stock on Friday. Such insider selling often attracts extra scrutiny when there’s little else in the news.

The timing is crucial since UiPath continues to behave like a sentiment-driven stock. Even minor cues—insider trades, comments at conferences, or the mood on demand—can sway its price more than warranted.

Two key events next week will put rate-sensitive software stocks to the test: the U.S. inflation report and fresh investor meetings. UiPath is scheduled for those talks, and traders often latch onto any hints it drops between earnings reports.

Dines offloaded 45,000 Class A shares, fetching an average price of $17.1719 each, totaling about $770,000, per the Form 4 filing. The sale was carried out under a Rule 10b5-1 plan, which lets insiders sell shares on a set timetable. The reported sale price ranged from $17.04 to $17.36. (UiPath, Inc.)

UiPath shares fell 3.32% on Friday, closing at $16.32. Trading volume hit roughly 18.8 million shares, per market data. (Zacks)

In early December, the company reported revenue of $411 million, marking a 16% rise year-over-year, with annual recurring revenue (ARR) hitting $1.782 billion, up 11%. UiPath projects fourth-quarter revenue between $462 million and $467 million, and ARR of $1.844 billion to $1.849 billion as of Jan. 31. CEO Dines noted that customers are “accelerating their AI and automation strategies” and seeking “a unified platform.” (UiPath, Inc.)

Investors keep fixating on that outlook. Even a slight shift in ARR expectations, whether up or down, tends to hit the stock fast—especially following a weak close.

Macro factors could also come into play. On Tuesday at 8:30 a.m. ET, the U.S. Labor Department will release the December Consumer Price Index, a key report that frequently alters rate forecasts and, in turn, impacts high-multiple software stocks. (Bureau of Labor Statistics)

UiPath faces a simpler risk: the filing could grab headlines, prompting investors to read too much into it as a confidence boost—even if it was planned all along. Should buyers pull back at Monday’s open, the stock might gap down despite minimal company-specific news.

UiPath is set to appear at the 28th Annual Needham Growth Conference on Jan. 13 at 11:00 a.m. EST in New York, according to its investor relations page. (UiPath, Inc.)

Stock Market Today

  • Profound Medical: Top TSX Growth Stock Poised for Rapid Expansion, Q3 Revenues Surge 87%
    February 1, 2026, 9:22 PM EST. Profound Medical (TSX:PRN), a Canadian medical device firm specializing in MRI-guided ultrasound therapies, is highlighted as the sole TSX growth stock to hold for the next three years. The company reported an 87% revenue increase in Q3 to $5.3 million, driven by expanded installations of its flagship TULSA-PRO prostate cancer treatment system. Offering incision-free, MRI-guided ablation technology, Profound's procedures have gained Medicare approval with rising insurance reimbursements. Despite a net loss of $8 million, the company improved gross margins to 74.3% and ended Q3 with $25 million cash, supporting near-term liquidity. With 70 systems installed and 93 in advanced sales stages, Profound aims for 75 installations by year-end, making it a notable small-cap growth stock in healthcare on the TSX.
Opendoor stock jumps on Trump’s $200 billion mortgage-bond plan — what to know before Monday
Previous Story

Opendoor stock jumps on Trump’s $200 billion mortgage-bond plan — what to know before Monday

Intel stock jumps 11% after Trump meeting comment — what to watch for INTC before earnings
Next Story

Intel stock jumps 11% after Trump meeting comment — what to watch for INTC before earnings

Go toTop